Scinovex
article Open AccessTop 1% cited

Global distribution and prevalence of hepatitis C virus genotypes

Hepatology · 2014 · Vol. 61(1) · pp. 77–87
Jane P. MessinaIsla HumphreysAbraham D. FlaxmanAnthony BrownGraham CookeOliver G. PybusEleanor Barnes

Abstract

Although genotype 1 is most common worldwide, nongenotype 1 HCV cases—which are less well served by advances in vaccine and drug development—still comprise over half of all HCV cases. Relative genotype proportions are needed to inform healthcare models, which must be geographically tailored to specific countries or regions in order to improve access to new treatments. Genotype surveillance data are needed from many countries to improve estimates of unmet need.

Hepatitis C virus researchLiver Disease Diagnosis and TreatmentHepatitis B Virus StudiesGenotypeHepatitis C virusPopulationGlobal healthVirologyDemographyMedicineBiologyEnvironmental healthPublic health

MeSH terms

GenotypeHepatitis CHumansPrevalenceHepacivirusInternationality

Funding

  • National Institute for Health and Care Research
  • Imperial College London
  • Medical Research Council
Citations
1,565
FWCI
90.22
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Cited by
EASL Recommendations on Treatment of Hepatitis C 2016
Journal of Hepatology · 2016 · 976 citations
Approved Antiviral Drugs over the Past 50 Years
Clinical Microbiology Reviews · 2016 · 1,404 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.